203 related articles for article (PubMed ID: 8104783)
1. Carbamazepine-valnoctamide interaction in epileptic patients: in vitro/in vivo correlation.
Pisani F; Haj-Yehia A; Fazio A; Artesi C; Oteri G; Perucca E; Kroetz DL; Levy RH; Bialer M
Epilepsia; 1993; 34(5):954-9. PubMed ID: 8104783
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of human liver microsomal epoxide hydrolase by valproate and valpromide: in vitro/in vivo correlation.
Kerr BM; Rettie AE; Eddy AC; Loiseau P; Guyot M; Wilensky AJ; Levy RH
Clin Pharmacol Ther; 1989 Jul; 46(1):82-93. PubMed ID: 2501059
[TBL] [Abstract][Full Text] [Related]
3. Impairment of carbamazepine-10, 11-epoxide elimination by valnoctamide, a valpromide isomer, in healthy subjects.
Pisani F; Fazio A; Artesi C; Oteri G; Spina E; Tomson T; Perucca E
Br J Clin Pharmacol; 1992 Jul; 34(1):85-7. PubMed ID: 1352988
[TBL] [Abstract][Full Text] [Related]
4. Sodium valproate and valpromide: differential interactions with carbamazepine in epileptic patients.
Pisani F; Fazio A; Oteri G; Ruello C; Gitto C; Russo F; Perucca E
Epilepsia; 1986; 27(5):548-52. PubMed ID: 3093212
[TBL] [Abstract][Full Text] [Related]
5. Influence of carbamazepine-10,11-epoxide on the serum level of valproic acid in epileptic patients on combined treatment with carbamazepine and valproic acid.
Minkova GD; Getova DP
Folia Med (Plovdiv); 2000; 42(3):16-9. PubMed ID: 11347330
[TBL] [Abstract][Full Text] [Related]
6. The influence of polytherapy on the relationships between serum carbamazepine and its metabolites in epileptic children.
Liu H; Delgado MR
Epilepsy Res; 1994 Mar; 17(3):257-69. PubMed ID: 8013448
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of epoxide hydrolase by valproic acid in epileptic patients receiving carbamazepine.
Robbins DK; Wedlund PJ; Kuhn R; Baumann RJ; Levy RH; Chang SL
Br J Clin Pharmacol; 1990 Jun; 29(6):759-62. PubMed ID: 2116161
[TBL] [Abstract][Full Text] [Related]
8. In vivo and in vitro correlation of microsomal epoxide hydrolase inhibition by progabide.
Kroetz DL; Loiseau P; Guyot M; Levy RH
Clin Pharmacol Ther; 1993 Nov; 54(5):485-97. PubMed ID: 8222491
[TBL] [Abstract][Full Text] [Related]
9. Correlation between plasma carbamazepine-10,11-epoxide concentration and drug side-effects in children with epilepsy.
Schoeman JF; Elyas AA; Brett EM; Lascelles PT
Dev Med Child Neurol; 1984 Dec; 26(6):756-64. PubMed ID: 6440825
[TBL] [Abstract][Full Text] [Related]
10. Carbamazepine intoxication with negative myoclonus after the addition of clobazam.
Genton P; Nguyen VH; Mesdjian E
Epilepsia; 1998 Oct; 39(10):1115-8. PubMed ID: 9776334
[TBL] [Abstract][Full Text] [Related]
11. Valproic acid-carbamazepine interaction: is valproic acid a selective inhibitor of epoxide hydrolase?
Svinarov DA; Pippenger CE
Ther Drug Monit; 1995 Jun; 17(3):217-20. PubMed ID: 7624916
[TBL] [Abstract][Full Text] [Related]
12. Disposition of valpromide, valproic acid, and valnoctamide in the brain, liver, plasma, and urine of rats.
Blotnik S; Bergman F; Bialer M
Drug Metab Dispos; 1996 May; 24(5):560-4. PubMed ID: 8723737
[TBL] [Abstract][Full Text] [Related]
13. Carbamazepine-10,11-epoxide in therapeutic drug monitoring.
Potter JM; Donnelly A
Ther Drug Monit; 1998 Dec; 20(6):652-7. PubMed ID: 9853982
[TBL] [Abstract][Full Text] [Related]
14. Carbamazepine drug interactions: the influence of concurrent drug therapy on serum concentrations of carbamazepine and its epoxide metabolite.
Wang RB; Liu LT; Yiu CH; Chang TY
Zhonghua Yi Xue Za Zhi (Taipei); 1990 Apr; 45(4):222-32. PubMed ID: 2168269
[TBL] [Abstract][Full Text] [Related]
15. The effect of clobazam on steady state plasma concentrations of carbamazepine and its metabolites.
Muñoz JJ; De Salamanca RE; Diaz-Obregón C; Timoneda FL
Br J Clin Pharmacol; 1990 Jun; 29(6):763-5. PubMed ID: 2378792
[TBL] [Abstract][Full Text] [Related]
16. Lack of interaction of gabapentin with carbamazepine or valproate.
Radulovic LL; Wilder BJ; Leppik IE; Bockbrader HN; Chang T; Posvar EL; Sedman AJ; Uthman BM; Erdman GR
Epilepsia; 1994; 35(1):155-61. PubMed ID: 8112239
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic-pharmacodynamic relationships of (2S,3S)-valnoctamide and its stereoisomer (2R,3S)-valnoctamide in rodent models of epilepsy.
Isoherranen N; White HS; Klein BD; Roeder M; Woodhead JH; Schurig V; Yagen B; Bialer M
Pharm Res; 2003 Aug; 20(8):1293-301. PubMed ID: 12948028
[TBL] [Abstract][Full Text] [Related]
18. Carbamazepine/valproic acid interaction in man and rhesus monkey.
Levy RH; Moreland TA; Morselli PL; Guyot M; Brachet-Liermain A; Loiseau P
Epilepsia; 1984 Jun; 25(3):338-45. PubMed ID: 6426944
[TBL] [Abstract][Full Text] [Related]
19. Thyroid function with antiepileptic drugs.
Isojärvi JI; Pakarinen AJ; Myllylä VV
Epilepsia; 1992; 33(1):142-8. PubMed ID: 1733749
[TBL] [Abstract][Full Text] [Related]
20. Valproic acid-induced carbamazepine-10,11-epoxide toxicity in children and adolescents.
Rambeck B; Sälke-Treumann A; May T; Boenigk HE
Eur Neurol; 1990; 30(2):79-83. PubMed ID: 2111243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
